0001664710-22-000027.txt : 20220601 0001664710-22-000027.hdr.sgml : 20220601 20220601160127 ACCESSION NUMBER: 0001664710-22-000027 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20220601 ITEM INFORMATION: Submission of Matters to a Vote of Security Holders FILED AS OF DATE: 20220601 DATE AS OF CHANGE: 20220601 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Keros Therapeutics, Inc. CENTRAL INDEX KEY: 0001664710 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-39264 FILM NUMBER: 22987280 BUSINESS ADDRESS: STREET 1: 99 HAYDEN AVENUE, SUITE 120 (BLD E) STREET 2: LEDGEMONT TECHNOLOGY CENTER CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 617-513-8774 MAIL ADDRESS: STREET 1: 99 HAYDEN AVENUE, SUITE 120 (BLD E) STREET 2: LEDGEMONT TECHNOLOGY CENTER CITY: LEXINGTON STATE: MA ZIP: 02421 8-K 1 kros-20220601.htm 8-K kros-20220601
0001664710FALSE00016647102021-09-022021-09-0200016647102021-08-042021-08-04

 
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
 
FORM 8-K 
 
 
CURRENT REPORT
Pursuant to Section 13 or 15(d)
of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): June 1, 2022
 
 
Keros Therapeutics, Inc.
(Exact name of registrant as specified in its charter)
 
 
 
Delaware 001-39264 81-1173868
(state or other jurisdiction
of incorporation)
 
(Commission
File Number)
 
(I.R.S. Employer
Identification No.)
99 Hayden Avenue, Suite 120, Building E
Lexington, Massachusetts
 02421
(Address of principal executive offices) (Zip Code)
Registrant’s telephone number, including area code: (617) 314-6297
 
Not applicable
(Former name or former address, if changed since last report.)
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
 
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
 
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) 
 
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) 



 
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) 
Securities registered pursuant to Section 12(b) of the Act:
 
Title of each class 
Trading
Symbol
 
Name of each exchange
on which registered
Common Stock, $0.0001 par value per share KROS The Nasdaq Stock Market LLC
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.
 
 



Item 5.07     Submission of Matters to a Vote of Security Holders.

On June 1, 2022, Keros Therapeutics, Inc. (the “Company”) held its 2022 Annual Meeting of Stockholders (the “Annual Meeting”), at which a quorum was present. At the Annual Meeting, the stockholders of the Company voted on the following two proposals: (1) to elect two nominees for director to hold office until the Company’s 2025 Annual Meeting of Stockholders and until their successors are duly elected and qualified (“Proposal 1”) and (2) to ratify the selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the independent registered public accounting firm of the Company for its fiscal year ending December 31, 2022 (“Proposal 2”). Proposal 1 and Proposal 2 are described in detail in the Company’s definitive proxy statement filed with the Securities and Exchange Commission on April 18, 2022. The final results of the voting on each proposal are set forth below.

Proposal 1 – Election of Directors

The Company’s stockholders elected the two persons listed below as directors, each to serve until the Company’s 2025 Annual Meeting of Stockholders and until their respective successors are duly elected and qualified. The votes cast were as follows:

NomineeVotes ForVotes WithheldBroker Non-Votes
Ran Nussbaum18,330,1181,822,7870
Mary Ann Gray18,332,3691,820,5360

Proposal 2 – Ratification of the Selection by the Audit Committee of the Board of Directors of Deloitte & Touche LLP as the Independent Registered Public Accounting Firm of the Company for its Fiscal Year Ending December 31, 2022

The Company’s stockholders approved Proposal 2. The votes cast were as follows:

Votes ForVotes AgainstVotes Abstain
16,436,64103,665,697

There were no broker non-votes with respect to Proposal 2.



SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 
KEROS THERAPEUTICS, INC.
By: /s/ Jasbir Seehra
 
Jasbir Seehra, Ph.D.
Chief Executive Officer
Dated: June 1, 2022

EX-101.SCH 2 kros-20220601.xsd XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT 0001001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 3 kros-20220601_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT Entity Address, State or Province Entity Address, State or Province Entity Tax Identification Number Entity Tax Identification Number Title of 12(b) Security Title of 12(b) Security Entity File Number Entity File Number Written Communications Written Communications Entity Emerging Growth Company Entity Emerging Growth Company Soliciting Material Soliciting Material City Area Code City Area Code Entity Address, Address Line Three Entity Address, Address Line Three Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Two Local Phone Number Local Phone Number Cover [Abstract] Pre-commencement Tender Offer Pre-commencement Tender Offer Amendment Flag Amendment Flag Entity Ex Transition Period Entity Ex Transition Period Pre-commencement Issuer Tender Offer Pre-commencement Issuer Tender Offer Trading Symbol Trading Symbol Document Period End Date Document Period End Date Document Type Document Type Entity Registrant Name Entity Registrant Name Entity Address, City or Town Entity Address, City or Town Entity Address, Postal Zip Code Entity Address, Postal Zip Code Entity Central Index Key Entity Central Index Key Security Exchange Name Security Exchange Name EX-101.PRE 4 kros-20220601_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT XML 5 R1.htm IDEA: XBRL DOCUMENT v3.22.1
Cover
Sep. 02, 2021
Aug. 04, 2021
Cover [Abstract]    
Document Type 8-K  
Document Period End Date Jun. 01, 2022  
Entity Registrant Name Keros Therapeutics, Inc.  
Entity Incorporation, State or Country Code   DE
Entity File Number   001-39264
Entity Tax Identification Number   81-1173868
Entity Address, Address Line One 99 Hayden Avenue  
Entity Address, Address Line Two Suite 120  
Entity Address, Address Line Three Building E  
Entity Address, City or Town Lexington  
Entity Address, State or Province MA  
Entity Address, Postal Zip Code 02421  
City Area Code 617  
Local Phone Number 314-6297  
Written Communications false  
Soliciting Material false  
Pre-commencement Tender Offer false  
Pre-commencement Issuer Tender Offer false  
Title of 12(b) Security Common Stock, $0.0001 par value per share  
Trading Symbol KROS  
Security Exchange Name NASDAQ  
Entity Emerging Growth Company true  
Entity Ex Transition Period false  
Entity Central Index Key 0001664710  
Amendment Flag false  
XML 6 kros-20220601_htm.xml IDEA: XBRL DOCUMENT 0001664710 2021-09-02 2021-09-02 0001664710 2021-08-04 2021-08-04 0001664710 false 8-K 2022-06-01 Keros Therapeutics, Inc. DE 001-39264 81-1173868 99 Hayden Avenue Suite 120 Building E Lexington MA 02421 617 314-6297 false false false false Common Stock, $0.0001 par value per share KROS NASDAQ true false EXCEL 7 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 8 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 9 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 10 FilingSummary.xml IDEA: XBRL DOCUMENT 3.22.1 html 2 25 1 false 0 0 false 0 false false R1.htm 0001001 - Document - Cover Sheet http://www.kerostx.com/role/Cover Cover Cover 1 false false All Reports Book All Reports kros-20220601.htm kros-20220601.xsd kros-20220601_lab.xml kros-20220601_pre.xml http://xbrl.sec.gov/dei/2021 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "kros-20220601.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 2, "dts": { "inline": { "local": [ "kros-20220601.htm" ] }, "labelLink": { "local": [ "kros-20220601_lab.xml" ] }, "presentationLink": { "local": [ "kros-20220601_pre.xml" ] }, "schema": { "local": [ "kros-20220601.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://xbrl.sec.gov/dei/2021/dei-2021.xsd" ] } }, "elementCount": 26, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2021": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 25, "memberCustom": 0, "memberStandard": 0, "nsprefix": "kros", "nsuri": "http://www.kerostx.com/20220601", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kros-20220601.htm", "contextRef": "ifb4424b8d80d492ab4072442bea6fb8b_D20210902-20210902", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "0001001 - Document - Cover", "role": "http://www.kerostx.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "div", "body", "html" ], "baseRef": "kros-20220601.htm", "contextRef": "ifb4424b8d80d492ab4072442bea6fb8b_D20210902-20210902", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag", "terseLabel": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code", "terseLabel": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2021", "xbrltype": "stringItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date", "terseLabel": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type", "terseLabel": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One", "terseLabel": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two", "terseLabel": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three", "terseLabel": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town", "terseLabel": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code", "terseLabel": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province", "terseLabel": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key", "terseLabel": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company", "terseLabel": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Entity Ex Transition Period", "terseLabel": "Entity Ex Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number", "terseLabel": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code", "terseLabel": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name", "terseLabel": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number", "terseLabel": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number", "terseLabel": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer", "terseLabel": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer", "terseLabel": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security", "terseLabel": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name", "terseLabel": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material", "terseLabel": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol", "terseLabel": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications", "terseLabel": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2021", "presentation": [ "http://www.kerostx.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 0 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r5": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r6": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r7": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" } }, "version": "2.1" } ZIP 14 0001664710-22-000027-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001664710-22-000027-xbrl.zip M4$L#!!0 ( "R P51$3&3O*1@ (C( 1 :W)OU;XKS2_W[^BCR9%29,\*E/- MQQZ55*Q*DHPMGU!L*";CQ%5<3_MA/OA3::3HH;6U=75T5KY1B%%]L$#F;?$4)]R;>0>^ M%R^BRSNEM]*8]A,_BGLTA;$1E6E8,K%";HB%HMV'^R6>WFER,8D_:T^6,+"> MR--*&+]E3E;!E&AX((K?$@8/@X=8(@F6S/+O7C]FBXO'+DWRXJ60]B^^%'@? MGYX48( Y93N?>SRE2+R/^=_#X/)+82_JIR"VV!D/X#4O__:ED/)1NI6-]];. M/_[QC\]ID(9\IQM'"18"*^D2^;R5__AY*Z_:C=AXYS,++E&2CD/^I<""9!#2 M<:D?]3D0$(Q*HB"/\X\!8[R??83G-NA.''AY^Z.TSOTOAUX6K)0L8/WT0P'U:4\TS8-2I0_TC?>@.S$-#_N,C[[S M<0$%#*IFRMG8+4>71W+]LJE4AZQ3N6P=6)U:YU2N7M=[S>MVV#IHCIK7QV/[ M.FS;GW"J5YWNM=UI=ZK7^QW[NMVV#^R@ZEQ<-:^_ MA=7&J58M?^O83E.UKT\G[YQ!6UJ_Y42C&M!0.ZA> WU*[: B->7#4:W\M5/M MG8Y:3O>JVJM"/RX4^\R\.G(J:?5$&ATYQU+UNBN?^Y8G:;)*L69I'E9=GV&J MF2HFFN&:/@R.;DF%'0DT7]=5@TB?MV8&]37'>!<@EPG8W0_I10'E.@G5CM*2 M'XPXPSX-A3JL!_WG@SZZ/^@>DTR/ZA@&GV.5JSJ&L6;8]8FJ2IZL21(K[.SO M'IU4[HWWUJQ^Q]SG,0<42Q; DH"L4I+-%B 1*,/B4@I@]*60!+U!*+ L^ZT= M"X&90:#B* $:/F_-UI&W?]OHA(8D&L;9MPQS2Q,IS"7C.5(XK8AG,#/]%C#Q MW0]XC#*"^,*Y:^_P^ZS"S+^\,_UIMO8!\#=BTV\P-<1I&8R-'4$4EBR8A*;O MW3Z[(9,]4'3Z9/I]VLC6#*,6\HU:7.6<2$S6-%7CA*I$<7U%DW5)U;FL3?AF M@G$R_;""?#.QI"[)M[M%E^7;UJSX;=V9![=@MLRGS(R=C]EIYZ1P]YW)--L+ M^KC-A2U9TM1!NGT5L+1=(I+T?X6LW,[G9$!!$]UX"][./^>5W%2U\SFE;LBG M-;I1#.1A+PI#.DAX:?IA>SJCY[80SE[:[M'X DAPHS2->B4-* C.0T\&F(: M!A?]DF##Y/$M<44I)S %-J1LVO+D<3%[M)6R^\\LLVA)#S^6BN3FV596=UX_ M=$'T_$M!*#,,!G?3M #*+3Y%:I'/=K_]V8"YB38N7'@ MYP63X)J7B&@V^WJ5#RZ8]]L9VR>#363!AG_]D^C2]LVXWO1[*QN)RIR<> M: F/7YQP)>$7Q/3;7NT_W:U"TE MR?=@;@9F0#D*:]2:0ZU'@"N7O0\,79,Q XI+QJ*NO1,T[-?J5?2*3LYT:2EW MT=_3E1E-79GJ05-N7C?EEK,+KL@NLB?JWF[ >MLB?J@?;WNW;G6[>Z M;XZKU][UN:MKBL%O#V])6 ]@]]8KMH'KE1ZWNK+Z5\V,8)T/:3U$:H1/NB25:1!04Q8AH&^S3 MZG<@\E':YH+V81RD 51<&7EMVK_@:-=+$3PFEJ(^W(\[#T/K^?A>_V0U:7@\]6WRNK\(DC$WF9JPY,_#N,\Z9PIDF=) M.L6*F^UTF1HV?<:QQ5SN2\0CQ/<+.]]Y'"7(:?.8#O@0A#S91(=]KS@/>.]I M:4A+B=1&943!HA""(";B^$8 $$U0,N">6%1G*.BC($T0V" P+\<++*@UDJ^1 M?)60?"V/"^71LHJF1IXCC@HIRHJUE#@^Y1G4:BTGY+\UL:K\%$6?%IC*GI9+ MTD+EGRJWA')YF[;Q88H^ FXK 5[+S;4_,]^>LX]^SWP#$R2*P77.@M).4G!> M]Z)A/XW'>Q&;]6Q%3)W8Z4[Y((XN13T?U*7-8V1:3G-<=:IJS0F!#C#YRNVP MV>D2^Z!Y;1]4KNW.Q1C,O['=.)R+D1F$=N=P5+V^T&H-H+U7E6H'9T'-.95: M0'M3Q,^4#Z]LYY T!8W.[FR,C$0-L J9A E8C5C5B(I-ZEO8T)@A>:Y/N4D+ M.V4>TBL:\P?]X<=58LE=Z!SL7UV^EYZ05TZ.AP M$CWF91/G6AN7UL;C66W4?=4WN&)A7?$-K,K,PJ9D$&SZ!I.(*;FN(K9I"2;$ M4$S=_*DZ/M_N>S@\ZRT78):+'-C(C#"Q-16E;1ZCSC .$A9D>U;+^Y&OOT*Y M7&\B'P5W;=!/<]&&*PZS\YU\/93]4"*Z%_5Z09)\2(D4YA7*$7TMC+^#,!X6 MZ\63(JKT!F$TYO''D\A98P/947&18#ZPTB/?6^FQEE]HT9^QT'*_^N<*T.1] M+ J7C+PCJV90OL@FVBYC,4^2R7]'0 !9&Y./&9/2_-+*D5(/^5_U<:O!!JZL MZJVR'4!;(]MI!ZUR=V27F\26OW7MQBGPY5ANE2^@9Z>C6L/V[6-P#'6+R::% M%5>9"E-\RRWL6!;ZBXY!(='N)>\/'UR@65).=^. AK^V M@[")GMCF1]<->:T;;ZH;M>-SDS"A%1JF5-:PZEL<=,,CF%-?TF5?)CH%W3@9 M!N"8@%RLE>+-E4)9*\6;*@70>TZ)9FJ2:6"F>"96*3.P:S&*== /!I.)YOJ\ ML/-U&(3"C$$+SKRNCB6Z8I*]!Q]KL1-=K?>8WEJNF^<:C*%J:!SKS-*Q2CC! MKJ+*F%B:(>O<99)'"CM'?)2?"UNC_=OH1+8]6XM_Q-%ED*7W6._.KI3F=';/ M#RIG)#53WN$K6P4Z5)0KWV,.%IFOQ\4ECU):=W MWV9ZHVZ]K^;_B$"UPU8PR*,RUFK]J%K/;3-9AF[I,C4Q8ZZ/5<^WL&F0[#2" M+IF,$6I8A1U)5F7R]!VFI1:\WFR3=,E%T8EDB0C>00S323"@(>(C[@W3X%($ M]OJ!QY-/'V6[^^V6OE=M( $5D("%3RM\6&%).+T]2_"O?YHR,;83E/*0#]I1 MGZ-^MB.S*78+PV'F3]&84Q@\QDMHXQ616+@BN]#4A\7>7SK?0,XMR5.(:E(L M&ZJ"15H9#%XOP91223.9P;FF%W9T8LPCYZ?7/(IW%('R_1"2\8&#+WYI9*[. MP9CT/$U3,7.)'REN4T &.NC_.PP0XEP-5%(D^D9 MV^+Z*,_Z*,^*'^59;.>\D^^[U^9>-SN<#X 11V!MB_ M-QHAEX?1E5 V\5"H M)#+Q=^0'H;!N@@1,G93W&2AA&H$>]H9A2OL\&B;A&"4T#1)_G+TY>2%R87CR M"(%),H [1_.&4 \H>'\\?>:#L$=7XCVQ8!2(4)VD].J:K?\>BFV!ZAK/.A,E M%Q7EN2>)?H(66E'5ESN\]!HQDN^A5:]H6C;B( 7%$S%LP_XDZ"99T3RQO[0< M8S?..K9<4>U.ES3E;Z%]<-:M=KI2J_RU6W5$_MC3JV;G4&HVFO-Y8DFK456: MSH5<<\XZS=ZIU&H4"0'GCL#PR2=R=33L$\4 M<"FX[F/P,CA63$W75%]58*0$#%B&JFZ_?@3^^TGQ1-2@#W=E#0WN9*.I#P'8 M5%F;0/A1VV6#&&AOOXYD12I"P646 M:P_M*PKEKJ:\"Z(NEK6'\96#\! ML]<#K>E?5,$ $YN.OR.FMSI-P'-/M>7]H%9F/?O@>-QJ? ,Z]P'?CY5JIZE5 M#TZ!GMWY)?:>W;D &BZ49N,0WF_"// M;/;.NLT&X'O9&\,\<=5RH._["S"= MP'AP7],Q<3T#JZJD8TL5Z8^9ZEFZ)\$H>7\$IM_*&>I-!.T^H!.58B+?P?29 M;%TWB*Z"CF94I)IS,:Z5!7WU;JWM@PJ(!XU<6F;E*L MR[*K$.+ZGB[_$1 /\H:].P+WJ/U.5(;E#??3\N>.?&0)_0=1$@AB M2C$/J=C2O9?B_Q9[,QB5;E^A;A*%P_3^*X_="I#_;<>W WK!L1MSVL74AZFP M1,,K.DX*6R]_%\%ZTEM/>BN(%&\WZ1TFR9#'O_G45VO8X-6<2G;CE( G S2$ MW59C/["=>M?.5JPJ*K04-COW;C;2FC)X->(F)><4/!E/JC7J(7@Z!+PBDMUX MY(A8OK/ 7C3U$8L91*$6YIP2K'J*@DW)M;"ORU21/=VW7&T]]2V<^A2.U0UO MN:EO4O;I4]^=G1Y]B7U6EWK=BS@"DO"$<7[V;_O-G,3;);Q\EX;'G,TP;Y*% M.N<$R8R'R=8-<*WTR$;-*_;O65MUJSK$**NF*^>*HXJ:A;R^5T^ZV) M59^TZSU_VOEG>>T>5(HGY)O[<^MX+,S@L.:)[N< 81UQ.FJ>7]]K("VF2 M+#%Y/Z?O'S8T]L4[NWH9(YR8BIZLTO&\)>\;&_?<*%SZ!,E:;G\ON;4G*;DS M\.(3(_OC27'41U?M +IP:QD_G.[DR<,]L2RSD,S5#(9[][-'$^=D3&0WFQ _ M\H)!^:S=.CC6;&=WW'3..O;!J6H?5*2JPT([6_?N*H).NU>97S!0[<9^MU7N MDFKY6]L&&L5Z>],Y'MGRJ61#OVJ.)U>=0[EY9H[O+1BHEL0]72(BG9V!5:9S M3'7J8^)K&N7<-S73+>R(!1P0]Y,T\KJ;Z'\SEX2@ 8W1)0V'' W$U;;MY^6! M76UT?^F#@VM]?[Z^3^R=W'I8*_L2RCZ74U;7-,4SN8=-RY2QZLD&-A7?PHHG MN18GEFN86F'G>[UVLM;CM1Z_^KP]75_-;^29SQ(@#,,/GR#@[51][B2Q2:FN MJMS"NDG%;3],P:ZN,ZQS334T32:FQ,&#;'-DTX31O_.Y'55IW.4I.CK:>_Q\ M\6H?9SCL,['8SY$[1EYVM '(ZH+%SK-LM'/G#H($ 8D M;#S(+I87U+7P7L1II6(3XO:].]46E[XZ\9W&I?( CU\]1\&TX8.LW;V\V46; MCVD\_)BNQ"\=TQR=2Z;N%S?M'I[Q5)\$O: M/#Y7"-<\;L*,SQC!@LO@XH,!H$A,LG1?,E5EB3CGUSHY^RQK_+?:G7V;D[-/ M=;X^T*'9/S>*<*7L[*4N NT,DS3PQ^_DRAZFO(>THF2@7,CN_ST9NI-[ ,04 M6J4I#%\BIE>*SJ+\(N^ITXK^BD)0MZ3X]'XO&M3WP%8B(B)J?73W0NM-]-#- MKVA#F!0BTXTL;4_,YNP;V?Z$VCQDV?VIH@ZTV^\/P7JI))$XE',$1N&XQM[4Y3] M&RK++Z[=F'#RQZ0#B-R,BBBX(6>=$;>53,[?)UD]0L;=_(?=(0M2E-V! 0+/ MITS[&H&Y*;Z4)SW.V%GF822*H7_1WF ;.=$0[&1T=/1#>,?B-3"A^4 8P-DU M]W=BQ=P0[+\[%JT?Q+WY 1(,%F+D!PE,1DA<18^@+E&\S#TN,N<@92*J]WLN M3WM>1+?A*!0M,_A#8%8R#-,;F059S02E MG^^/3N4SHS_AJ6 5-)SE9+B/0>\*-(O1]\Z(9,PEVZ@R%<2[0K9:?5D\V3D+ M!&4&=Z:J*@8R0Q?X482;AD(=V"23AEA.FO9Z,Q]ED3F#QY# _5A3')%*UJ:\@HQB-8KW*U+S*)N M/9>@-;&/$:N]B&?V6P0;VKD5]!);@"\1[?DA>':6P>=^%*^Y]F2N-<"P$G[% MFG5/8-W7..J"C6Q'?9QQ\2D73M[G )@*_&=[V1]J3[\.3=K#)''IL/.I5'1KS;8G0I:TJ2GZFFN_!DP/I$9:S44\^681 MKT[OW/5Z$[[TJDO,AW>6F.NW2\P_\B7FW=LEYOV?+#'OYTO,3;'$7'E@B?FW M6(O,TOA>\KN+X'_PVAXIJN9R.3W>?P7JHQ&KJ,N=L?XCELO62S_/Y]KN!0WZ M2;KFW-,YYR8I\.[]EGU6S]0B^J:JZ)NZ2M9.]2O8KFL^/I>/RJ:N:YNZ9:RZ M+_"@X0E&8V8Y]B/DY@O/_:B/<[LRBXN8;#R+?>T[UN>#(5/K6+Y5N=OLY/# MWG5.ZY6358_H_W$G"CX/TO]["-ZDB-!)ECQ.L[DHNC^+C/#H,,G".()D'1VF[2B&SK$%YW,^QJU$ M]R#US8.M5;EH:L9SG#^S*!O+;>@_+?FD09[GI/V45JUH/"V9_AR(_C2WU!-F MX5\M^OP[2-\KD^!B1/Q>J==.D/-7I;[[HW+J'.Z=;*)#>Z^XR-1^T:'0G\'? M#YBI\>NXM(1=^9&V8E[B^M:5Z]16LH6^T<0-8IA5>3NF3W$UGX$E'X$GRV<+ M>/% BD>.0;T'-V:D8Q/]:!?+#UO\JT+T7CO@/AB'TPNE:UE0?SQGI7V40^]E MFG)6FCG8L>H^UY8;L3'\UTY[X<[_ U!+ P04 " L@,%4U"_W5FD" !K M!P $0 &MR;W,M,C R,C V,#$N>'-DS55;:]LP%'[/K]#\//F:+(EI4EA+ M89!MT+6T;T.6CQ,16_(DN7'__23%)G7:K OL86"P?,[WG?N1+R[;JD1/(!43 M?.%%?N@AX%3DC*\7WOW=#9YYE\O1Z.(#QH^?;U?H6M"F J[1E02B(4<[IC?H M(0>U1844%7H0",9+1[H2];-DZXU&<1C'QUJ99C">%EF4X"D9YWB!R&,9X7$<'39)9#E"49_50XHZU* M%=U 19!)C*NT50MOHW6=!L%NM_-WB2_D.HC#, H>OZY^.*C784O&MP-TF\FR MQR>!56=$00_?2C$TO@4CT:U/1178;,-/8>0AHK5D6:/A1LCJ&@K2E'KA-?Q7 M0TI6,,A-Q4NP-1T 7J@UD6O0WT@%JB84WO>Y'"%D*\&J6DB-^)O,KA31?#X/ M6IN;A_:56PE*M!N'DZ5P>&R/.(IQ$OFMRKW@K]P.#3&N-.$4SO%MOG#/^QU>G8+; [:'H4_"N=".;R6=K*X9+\1> M8$0V\+2/_A:*?E5>S?\;(^)>*9%4BO*=>0IJ*6J0FH%ZN3O.P$9"L?#L!N%^ M:G^6)/--)#WDE8-A"ZPZ,!0H5X=,>JY^K@U7F0:4L*_-_YQX+>'E3!WOX>L[/[VR\F;Q?G<8WMCO;D<"L:9&[C0W*KF0?CP ME\#(L2Z"8^R1E49!_ITOW?DXMX[<0?Y I*2D37D^[Q#625HG[&O7[58P7*[] M]XL%=(+]5B]'OP%02P,$% @ +(#!5)%A2X(V"P ]6@ !4 !K'I&CU]:]W M5POOI\Z6<9J\.4$OX8FG$YFJ.+EX<_+]_ ,(3WY]^^+%Z[\ \,<_OIYYOZ7R MYDHGN7>::9YKY=W&^:7W0^GEGY[)TBOO1YK]&?_D +PMWW2:7M]G\<5E[F&( M\=-7LU="4V8$(H!QJ@!5V@,A$HC080,3!ET$2=_OBK^$'RI/9M;D,L^O7\UFM[>W+^]$MGB9 M9A99*GI>>[]7EM;8H_@4VS4#Q%$ 8$/3R;JE.WK[PO)4=6;K0 M7[7QBK^_?_W8VF4T*UK,$GU1?+)?=!:GZEO.L_R,"[VPZLMH^?VU?G.RC*^N M%WKSW&6F37/8199M12U41H5*%!0J_]K6V6R _ /IS>M:#R"N3/?3H33N\O33 MP>2>V_%!'U]PI9O!DE=?J/>)&NN[^]#58.G'5WRHKT6:\\4(7XO';BJ2%\43 M9_;1NILBT([!M.QG/717I.J[7"=*KT;+K=!>K-Z/Y^R2/\_MW2F5Z MN;2C5*X_9U^R]&=L1_4YPUS@**0 (6, I42"$/H,"(IT2+0V#,%Y_O#=GNL$ M?/^VD5'VU:VC$X=,\Q9B;=CT)I./M>YJT53 ;.TJJETX2_B57E[S]1NLVF): ML$K@[4JKMQ;[BU?*]=+,VPA^/7M,<8"_B]%<6TS5L%1NB5H4DX^I&*CN[ M\0CETB926K'4\N5%^G-F0UA+,"H>@.)!R>+>P+/:)_PNVZCFF=QC_[K%3*8V MUG4.MCZ)8E[IEEZ>NGTY5K9:$2?VXU ZLS/AAH0:OK+G_.ZCLM/AV,2K^=RG MFRNALSF#&HLQZ"PQXT!HT);Y)&'A3T)UL>%?6]P'QB^:7F3V<@( MB_,X7^@YA((:(B$0F!% &=- ,$( %PPS+*G& >DZ%CP-/C7\2U%>:CR$_R;^ M[FWD=J>^YMY^T(=XUP0KHM[UX4UX*-!FY;&E566]OTK=L?XH5>5Q(D MB)1*$A H:DMU@#6(D H!,48RH01C/G:2,,T[3Z(;>Y@:GFN1WK;*[H@VV[B?T\'F'!E6 M1U^<@-V9>R]JFR..AN[.A*K\[F[8M[*^O]+919Q<_#-+;_-+&_R:)_?S* R1 M,;:T$J@DH%AKP"D4@#/"J&),2NVX'F[L9VI KZO,1JNW$NNMU;K6WF9KNY;A MP8:-4Y%=O>I1G7OGQC',;\7=N"8OY8AYB MPA 3'$ B;!F7(@(\8 HPI 42R-?"#SNO?VOAIX;\HT)O(]%A]5MWK\/Z=Y G M1Z;:Q0ZWU6]KUOW6O_5PXZV 6U/96@.WMW+']+38$L\T/TV5GD<("4J) 4)P M""@)?!#9$@V,A)KYVB <5ZKI3N676?A[[6G!D$CMF M[P1A4ZJ]\-L*-!IX3?*KR#6^WG=BO+X"M?[K+$XTF5/?(*'"$ 2&4T"%MHM; MC'P02B@9"S&T7/:Z=%SM96H8/KT,NG[@%6*]<_OUZ7OA>,O:KM/B@8:-,RGN MXU7_:\9-7@R_8+P5]7FN%C@H\XHF6D:>5R"7>04Z OAXC@B3- @E(-"N)V@(!8@$L4, -U!IGS)?#@8? M_U^!?WZ;#@ '[QRZ'%E\LTV9S# M8 8QWU>VO$NJ 64! 4(C#+C!AAO%,1:=>7\:?&J8E_J\4J#S 9::_%:"S8:IFUI5.EL;=-C/SW]J;-W8IEG7.9=]HBK[2?TK2IU M>?_9*/OO@;:)F[+MMT^\%6F\C>*F!+9VBAL;N'^/OF2Z.(^AK:+B5[;GQ8^3 MLL_&V-$J8(K@\MRP'S [K3/(3NM\ AB2&E&D#$:FZS#?WLW4!GRK%,B*5&^E MU2O%=A_[=_BZ'];#N'5DFMB)/#? '<5ZAKCO1VW;M MA[BW"4?FMF/^3J VYMJ+S>U(H^'8F$"5P.8&O<\LWIUG/%G&Q=[LZM?<2ZGQ4L>YH MU]V383Z-LWGB9%&?$XJM'@PYGE@/.O;9Q-:T&@XFMK<=/*W^N%S>Z*PZ"212 MPD!'&)CRC**E''"*H06?8QZ%5 9^9]SW=38U[&LSQY7BP\RTZU8[S[<'&3CV MK-O%NR&3[U93#C$%KP=_KHEX:YH[IN/M[W$?..P85-P*Z]O]E4@7A3TGF*70T\66P+<>ZLEEYU1]35@;'(W)E\+QRKF0ZBL PT.GQ5^4W,;;W> M=R/KJ[Z(BVM02?[)?DAS[G/-!(] ))!%SD@%(L0%X$H8%B(<8M+YSC--'4P- MO?7NS*-(KU#ING?UQ,2N^U;]K1EGSZJK*SVVJYI3'[!5]23@R-M4S>G4MZA: MV@T\RU?\Z.AS=I[>)G-?&R-MT01$"67Y51!$&$5 8%_R4'(=8$=^:WU,%.&' MTVGEK];2S"NT]CS#5S&T*\N#;!H'9S>'^I_=JWLP_.1>)>;SG-NK)]5Z:J^A MZ4# OZ3+G"_^'5^7OT$AB$1:A1S 4&E .0GL I<@((5B2/K(#\)^=X_=ZF;J MF*_$>E9MKY_Y-#KK"'MOOT;FO:M5_9%O=&(X]=MAGP?\QM1:V6]NW1?_4SO+ MS_CB8Z+TW;_T_5RQD$H3$<"(" $-I"6?AR&(($28JQ!)KMS(?]+#1*%?J_1* MF9[5Z4K[4R.[@C[ GG$8[^Y,#[A;LA_ ]=.((R/=DE"=YK:&_>_M^OY.7MK/ M3Y<+1$U8@) %5VOJ XK\<'5_&REL25=:ZY!V/JK5U,'4,-YH]#8B'5?9C2;N M9WBH-4=&V-&57G=Z;4I]T-U>MP*.?L?7IG2:[OK:V*X-WJKC9_;1VQ>;9^+5 M_Y/S]L7_ %!+ P04 " L@,%4K1&-2B4' E-P %0 &MR;W,M,C R M,C V,#%?<')E+GAM;-6;65/<2!+'W_TI>MG7+;KN@S!,L(R]02PS)FPF/+$O MBCJR0$&W1$C"P+??5 ,SYO"LC+2!_-*HI2IEYC]_74=*O/WI>KU:?(&F+>MJ M=XMMTZT%5+%.976ZN_7;R7MBMW[:>_/F[=\(^?V?'X\6/]?Q<@U5MSAHP'>0 M%E=E=[;XG* ]7^2F7B\^U\UY^<43LK?I=%!?W#3EZ5FWX)3SQU>;G0#2Y, $ M,5XF(A,H8KU71%%C07#C$OA_G.XH&CWW*I/HJ2224DY<9IX881.P($+4>7/3 M55F=[_0?P;>PP."J=O-U=^NLZRYVELNKJZOMZ]"LMNOF=,DI%E/$<:)8-O7;=K:>[-8W,K1U"OX"'G1__WMX^$#D^?0 MU&UWO1WK];*_OCRHD0;T=-.SN[F W:VV7%^LX/[<60-Y=^L80G[OKW5K[;!;CNH$IP&]6]@54='S1:]9K6?_1<^0"K MS=DB05EL[KH?VJ[QL2MH5#%RKHFVPA/I\]RBRYL4 MM!"W3^LO2[PQIH*S_J"7XU:*)^9N97F9W_>_N!-L6S@II%.!$%(^Q%$L/&=U M$ IBOBB,5G(6)!SBZJRYJ)N-\)]0?SBH+ZNNN3FH$Q2:6RV9Y40E[8B$)$B@ M.I%@??(J1 O)3 #&7SHQB!,Y=TZFTWD6V+PO5_#KY3I 4\08:,P^$>4%KJ59 M8L0"!))YQ-4VT,S8N#7$8XN#@%!S!^*%"LXB^R?^^C"A5F4N;[<==X$8#PX0 M5\)M!B*5R\0:%PC0%%02FE(W;DWQE^8'<:'GSL44VLX"DOV4, 7MW1_/2$*< @<$>.I"=*N,J6:I,6R*D>,9TX/ L#\>&-^GZ4S!$$7"-;.P&@B'A MJ M803Q$H/(+@;A' !D_G\!0PP"P_UX8'R?IG,"XP //S0G]555. 8,:#0$F$DH MBL<0,I<$(@*?0:8<_718_&EX6 V+_B!4O%#0.3&QV4I]:(Z;^DM912@8CT%) M'7 .=,@V1H5Q6$MX\-ZE1)/1$XX7CZP/HV/&)<[)I)T3(L=UV_G5?\J+S58[ M!V.UB)EPQR.1FC+B@F3$(.>6,N[DE( \L#T,CQE7/R>2]97AZ$>]_0;\K=], M\. XCGL^*B+QD 2G* F*AD2U4I:/?'#SE;5A ,RXYOEBZ5XYY?WCT=7Q65W= MEURR5CBQ"2"*!UP;^V")=SH22\$(*3TS9MSZX;'%8:F?<1ESE(2OG/[/3=EU M4!W4Z_5E=5=6:8O$O%#]=AFXL;@_BD"-;L,!!F7+X< M+^8KT_"I7I6Q[,KJ]!=&X+B!GF# A>WFF7[_.DCS(:,?A>-)1FXE83P(G-=4/Z]1 M26SPO"^YLL#E*!B^;7L8%#,N4TXDZ[S@.&S;2VB^CB5JC_Y+#",ZW"U;I8D3 M&@BE 67R.46OID3DB0?#0)EQV7)2B5][0H%XB9/B#8)]4G8K*!R36BN'.V6# MVV7I< BT3BI$W7H#@?O@QSTV?VQQ& XS+E:.DO"5TW_2^/[]UD\WZU"O"LMU MY-ZB DGVCGM'O-&&1!,,%3HR1L?-'@_,#7N?:L;UR)>+-Y,?_;OK>.:K4]B\ M_F.T]MIR1S1X'+F2UL1:"03=0QEP/ MVW&.LYZP.8V#&5$5%R)&1T1@$C4!28+"<2RFG(PUPH8<)B@W/FM\&!BS MKS>.%W8>?%SC6%>U9:__[>NC10K12NK1::DID2(8XC(HPD6F8%$<"WH*.)Y8 M'D;&C N1DT@Z"RP.4*_&KPYQY7O];[@I%'4Q]R KG/.(Y"SAPD/RY'@Q7YF&?=P&I7XK]'[E3PMA,\O!!W0F[L+_4?_?U5[;_X+4$L! M A0#% @ +(#!5$1,9.\I& B,@ !$ ( ! &MR M;W,M,C R,C V,#$N:'1M4$L! A0#% @ +(#!5-0O]U9I @ :P< !$ M ( !6!@ &MR;W,M,C R,C V,#$N>'-D4$L! A0#% @ M+(#!5)%A2X(V"P ]6@ !4 ( !\!H &MR;W,M,C R,C V M,#%?;&%B+GAM;%!+ 0(4 Q0 ( "R P52M$8U*)0< "4W 5 M " 5DF !K